Cargando…

The Prevalence of Occult Hepatitis B Infection among Blood Donors in Lagos, Nigeria

BACKGROUND: In occult hepatitis B virus (HBV) infection, the HBV DNA is present in the blood or liver tissue in patients negative for hepatitis B surface antigen (HBsAg) with or without anti-HBV antibodies. Thus, the absence of HBsAg in the blood only reduces the risk of transmission and is not suff...

Descripción completa

Detalles Bibliográficos
Autores principales: Akinbami, Akinsegun, Badiru, Mulikat, Uche, Ebele, Onyekwere, Charles, Ismail, Kamal, Olowoselu, Olusola, Oluwole, Esther, Suleiman, Aisha, Augustine, Benjamin, Olaosebikan, Hakeem
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6677000/
https://www.ncbi.nlm.nih.gov/pubmed/31413431
http://dx.doi.org/10.4103/nmj.NMJ_29_19
_version_ 1783440865738358784
author Akinbami, Akinsegun
Badiru, Mulikat
Uche, Ebele
Onyekwere, Charles
Ismail, Kamal
Olowoselu, Olusola
Oluwole, Esther
Suleiman, Aisha
Augustine, Benjamin
Olaosebikan, Hakeem
author_facet Akinbami, Akinsegun
Badiru, Mulikat
Uche, Ebele
Onyekwere, Charles
Ismail, Kamal
Olowoselu, Olusola
Oluwole, Esther
Suleiman, Aisha
Augustine, Benjamin
Olaosebikan, Hakeem
author_sort Akinbami, Akinsegun
collection PubMed
description BACKGROUND: In occult hepatitis B virus (HBV) infection, the HBV DNA is present in the blood or liver tissue in patients negative for hepatitis B surface antigen (HBsAg) with or without anti-HBV antibodies. Thus, the absence of HBsAg in the blood only reduces the risk of transmission and is not sufficient enough to ensure the absence of HBV infection. AIM: This study was aimed at determining the prevalence of occult HBV infection among blood donors in Lagos. STUDY DESIGNS: A cross-sectional study was done among 101 consenting blood donors at Lagos State University Teaching Hospital, Ikeja, between November 2016 and January 2017. MATERIALS AND METHODS: HBV DNA analysis and viral load were done at the Molecular Laboratory of National Sickle Cell Centre, Idi Araba, Lagos, for all the HBsAg negative blood donors screened by rapid kit at Ikeja. RESULTS: The prevalence of occult HBV DNA among the participants was 3% consisting of 3% prevalence of HBV DNA surface antigen and 0% prevalence for precore and core of the HBV DNA. CONCLUSION: The low prevalence (3%) of occult HBV seen in our study does not make it cost-effective to routinely screen blood donors or the general population for HBV infection using DNA polymerase chain reaction.
format Online
Article
Text
id pubmed-6677000
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Wolters Kluwer - Medknow
record_format MEDLINE/PubMed
spelling pubmed-66770002019-08-14 The Prevalence of Occult Hepatitis B Infection among Blood Donors in Lagos, Nigeria Akinbami, Akinsegun Badiru, Mulikat Uche, Ebele Onyekwere, Charles Ismail, Kamal Olowoselu, Olusola Oluwole, Esther Suleiman, Aisha Augustine, Benjamin Olaosebikan, Hakeem Niger Med J Original Article BACKGROUND: In occult hepatitis B virus (HBV) infection, the HBV DNA is present in the blood or liver tissue in patients negative for hepatitis B surface antigen (HBsAg) with or without anti-HBV antibodies. Thus, the absence of HBsAg in the blood only reduces the risk of transmission and is not sufficient enough to ensure the absence of HBV infection. AIM: This study was aimed at determining the prevalence of occult HBV infection among blood donors in Lagos. STUDY DESIGNS: A cross-sectional study was done among 101 consenting blood donors at Lagos State University Teaching Hospital, Ikeja, between November 2016 and January 2017. MATERIALS AND METHODS: HBV DNA analysis and viral load were done at the Molecular Laboratory of National Sickle Cell Centre, Idi Araba, Lagos, for all the HBsAg negative blood donors screened by rapid kit at Ikeja. RESULTS: The prevalence of occult HBV DNA among the participants was 3% consisting of 3% prevalence of HBV DNA surface antigen and 0% prevalence for precore and core of the HBV DNA. CONCLUSION: The low prevalence (3%) of occult HBV seen in our study does not make it cost-effective to routinely screen blood donors or the general population for HBV infection using DNA polymerase chain reaction. Wolters Kluwer - Medknow 2019 /pmc/articles/PMC6677000/ /pubmed/31413431 http://dx.doi.org/10.4103/nmj.NMJ_29_19 Text en Copyright: © 2019 Nigerian Medical Journal http://creativecommons.org/licenses/by-nc-sa/4.0 This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.
spellingShingle Original Article
Akinbami, Akinsegun
Badiru, Mulikat
Uche, Ebele
Onyekwere, Charles
Ismail, Kamal
Olowoselu, Olusola
Oluwole, Esther
Suleiman, Aisha
Augustine, Benjamin
Olaosebikan, Hakeem
The Prevalence of Occult Hepatitis B Infection among Blood Donors in Lagos, Nigeria
title The Prevalence of Occult Hepatitis B Infection among Blood Donors in Lagos, Nigeria
title_full The Prevalence of Occult Hepatitis B Infection among Blood Donors in Lagos, Nigeria
title_fullStr The Prevalence of Occult Hepatitis B Infection among Blood Donors in Lagos, Nigeria
title_full_unstemmed The Prevalence of Occult Hepatitis B Infection among Blood Donors in Lagos, Nigeria
title_short The Prevalence of Occult Hepatitis B Infection among Blood Donors in Lagos, Nigeria
title_sort prevalence of occult hepatitis b infection among blood donors in lagos, nigeria
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6677000/
https://www.ncbi.nlm.nih.gov/pubmed/31413431
http://dx.doi.org/10.4103/nmj.NMJ_29_19
work_keys_str_mv AT akinbamiakinsegun theprevalenceofocculthepatitisbinfectionamongblooddonorsinlagosnigeria
AT badirumulikat theprevalenceofocculthepatitisbinfectionamongblooddonorsinlagosnigeria
AT ucheebele theprevalenceofocculthepatitisbinfectionamongblooddonorsinlagosnigeria
AT onyekwerecharles theprevalenceofocculthepatitisbinfectionamongblooddonorsinlagosnigeria
AT ismailkamal theprevalenceofocculthepatitisbinfectionamongblooddonorsinlagosnigeria
AT olowoseluolusola theprevalenceofocculthepatitisbinfectionamongblooddonorsinlagosnigeria
AT oluwoleesther theprevalenceofocculthepatitisbinfectionamongblooddonorsinlagosnigeria
AT suleimanaisha theprevalenceofocculthepatitisbinfectionamongblooddonorsinlagosnigeria
AT augustinebenjamin theprevalenceofocculthepatitisbinfectionamongblooddonorsinlagosnigeria
AT olaosebikanhakeem theprevalenceofocculthepatitisbinfectionamongblooddonorsinlagosnigeria
AT akinbamiakinsegun prevalenceofocculthepatitisbinfectionamongblooddonorsinlagosnigeria
AT badirumulikat prevalenceofocculthepatitisbinfectionamongblooddonorsinlagosnigeria
AT ucheebele prevalenceofocculthepatitisbinfectionamongblooddonorsinlagosnigeria
AT onyekwerecharles prevalenceofocculthepatitisbinfectionamongblooddonorsinlagosnigeria
AT ismailkamal prevalenceofocculthepatitisbinfectionamongblooddonorsinlagosnigeria
AT olowoseluolusola prevalenceofocculthepatitisbinfectionamongblooddonorsinlagosnigeria
AT oluwoleesther prevalenceofocculthepatitisbinfectionamongblooddonorsinlagosnigeria
AT suleimanaisha prevalenceofocculthepatitisbinfectionamongblooddonorsinlagosnigeria
AT augustinebenjamin prevalenceofocculthepatitisbinfectionamongblooddonorsinlagosnigeria
AT olaosebikanhakeem prevalenceofocculthepatitisbinfectionamongblooddonorsinlagosnigeria